Status:
UNKNOWN
Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI
Lead Sponsor:
Sakarya University
Conditions:
Myocardial Infarction
ST Elevation Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.
Detailed Description
Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study. A basal routine echocardiography will be obtai...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients presenting within 12 hours of their first ST- elevation myocardial infarction that is successfully reperfused; and completed baseline echocardiographic evaluation and accepted participation in the study
- Exclusion criteria:
- Patients:
- With prior ST- elevation myocardial infarction
- Patients presenting \>12hrs
- Not successfully reperfused
- Not completed baseline ECHO evaluation,
- Not accepting participation in the study
Exclusion
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02299609
Start Date
January 1 2013
End Date
February 1 2016
Last Update
November 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sakarya University, Faculty of Medicine
Sakarya, Turkey (Türkiye), 54290